signal transduction inhibitor program (DWTI)

N/A

Report date: 2025/03/20 09:52:32
NME

Base Information

Drug Namesignal transduction inhibitor program (DWTI)
Drug Alias Namecancer/cardiovascular disease program(DWTI)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transduction pathway inhibitors
TargetsUpdating
Therapy Area/IndicationsCardiovascular DiseasesEye DiseasesCentral Nervous System Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesD. Western Therapeutics Institute
China Registration ClassN/A

Develop Information

Active CompaniesD. Western Therapeutics Institute
Inactive CompaniesN/A
Active IndicationsCardiovascular DiseasesEye DiseasesCentral Nervous System Diseases +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A